| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. (DYN) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. DYN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 5.28M | $108.20M | - | |
| Dir | 1.16M | $23.77M | - | |
| CEO | 368.2K | $7.55M | -2,683 | |
| Other | 169.2K | $3.47M | -887 | |
| Other | 154.2K | $3.16M | -145 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | Kersten Dirk87 | Director | Sell | 30,974 | $35.50 | $1,099,696.99 | -5.7% | -34.2% | -64.8% | |
| Sep 26, 2024 | Kersten Dirk87 | Director | Sell | 3,617 | $35.14 | $127,101.82 | -0.9% | -29.3% | -62.0% | |
| Sep 23, 2024 | Kersten Dirk87 | Director | Sell | 120,242 | $36.07 | $4,336,893.00 | -12.3% | -31.0% | -61.9% | |
| Sep 19, 2024 | Kersten Dirk87 | Director | Sell | 80,293 | $36.15 | $2,902,719.72 | -7.0% | -32.5% | -63.9% | |
| Sep 18, 2024 | High Susanna Gatti66 | Chief Operating Officer | Sell | 8,976 | $34.41 | $308,864.16 | -3.2% | -23.8% | -59.5% | |
| Sep 18, 2024 | Scalzo Richard William58 | SVP, Head Of Finance &Admin. | Sell | 1,390 | $34.55 | $48,024.50 | -1.4% | -23.8% | -59.5% | |
| Sep 18, 2024 | Beskrovnaya Oxana58 | Chief Scientific Officer | Sell | 2,339 | $34.55 | $80,812.45 | -1.6% | -23.8% | -59.5% | |
| Sep 17, 2024 | Kersten Dirk87 | Director | Sell | 4,592 | $35.10 | $161,198.16 | -0.6% | -24.6% | -62.0% | |
| Sep 11, 2024 | High Susanna Gatti66 | Chief Operating Officer | Sell | 5,270 | $31.89 | $168,060.30 | -1.8% | -13.1% | -59.6% | |
| Sep 11, 2024 | Beskrovnaya Oxana58 | Chief Scientific Officer | Sell | 2,161 | $31.89 | $68,914.29 | -1.5% | -13.1% | -59.6% |